Close Menu

thyroid cancer

NEW YORK (GenomeWeb News) – Veracyte and Genyzme today announced that the New York State Department of Health has cleared the way for Veracyte's molecular diagnostic test for inconclusive thyroid nodule results to be offered to patients in the state.

Results from a multi-center prospective validation study have confirmed the sensitivity and high negative predictive value of a gene expression test marketed by Veracyte to identify patients whose thyroid nodules are likely to be benign and who can thus avoid further diagnostic s

Quest Diagnostics considers mass spec-based protein tests an "extremely important area" for the company to pursue, Richard Reitz, medical director and chair of the Endocrine Division at Quest's Nichols Institute, told ProteoMonitor in an interview this week.

NEW YORK (GenomeWeb News) – Molecular diagnostics company Prolias Technologies today announced it has licensed intellectual property covering microRNA-based diagnostics from Cornell University.

The American Society of Clinical Oncology held its annual meeting June 1 - 5 in Chicago. The following are abstracts presented at the meeting focused on the application of molecular diagnostics to cancer prognosis.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Genzyme and Veracyte today announced a co-marketing deal covering Veracyte's thyroid diagnostic tool.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) — Veracyte said today that Medicare contractor Palmetto GBA has agreed to cover its Afirma Gene Expression Classifier for use in thyroid nodule diagnosis.

Using custom microarrays and bisulfite sequencing, researchers have garnered evidence of extensive shifts and variability in methylation patterns in the genomes of several types of cancers.

Building off data presented today at the International Thyroid Congress, the molecular diagnostics firm is moving ahead to launch its tests later this year that it says would reduce the amount of unnecessary thyroidectomies.

Pages

Following its departure from the European Union, the UK is to implement a fast-track visa program aimed at attracting scientific talent to Britain, according to BBC News.

ScienceInsider reports that researchers in Brazil are concerned that a creationist was chosen to run the agency that oversees graduate study programs there.

The Washington Post reports that researchers are quickly analyzing the coronavirus that has been causing illness and sharing their findings.

In PLOS this week: common variant associated with BMI in Arctic populations, analysis of microRNA markers associated with being born small for gestational age, and more.